These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12457730)

  • 1. N-methyl-D-aspartate-R1 receptor antisense oligodeoxynucleotide modulates pre- and postsynaptic expression of D2 dopamine receptors in the rat.
    Murata M; Suzuki M; Tanaka K; Tajiri K; Emori K; Kurachi M
    Neurosci Lett; 2002 Dec; 335(1):9-12. PubMed ID: 12457730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
    Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
    Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
    Silvia CP; King GR; Lee TH; Xue ZY; Caron MG; Ellinwood EH
    Mol Pharmacol; 1994 Jul; 46(1):51-7. PubMed ID: 8058056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
    Marti M; Mela F; Bianchi C; Beani L; Morari M
    J Neurochem; 2002 Nov; 83(3):635-44. PubMed ID: 12390525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates.
    Zhang M; Creese I
    Neurosci Lett; 1993 Oct; 161(2):223-6. PubMed ID: 7903803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
    Van Kampen JM; McGeer EG; Stoessl AJ
    Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway.